Stock Events

Stock Events

PolyPeptide Group 

CHF44.00
12
+CHF0.00+0% 11:10 Today

Statistics

Day High
44.05
Day Low
44
52W High
44.05
52W Low
14.19
Volume
2,434.09
Avg. Volume
-
Mkt Cap
0
P/E Ratio
0.3
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
May 22
CHF0.30
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

13AugExpected
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
-0.76
-0.42
-0.07
0.27
Expected EPS
0.0650745788
Actual EPS
N/A

Financials

-5.45%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
363.03MRevenue
-19.8MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0AAJ.LSE. It's not an investment recommendation.
Idorsia
3
IDIA.SW
Implenia
3
IMPN.SW
Apple
2
AAPL
Microsoft
2
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Bank of China
BACHF
Mkt Cap209.44B
Bachem Holding AG specializes in peptide technology, directly competing in the same sector as PolyPeptide.
AMGEN
AMGN
Mkt Cap236.38B
Amgen Inc. develops peptide therapeutics among other biotech solutions, overlapping with PolyPeptide's market.
Lilly(Eli) &
LLY
Mkt Cap1.02T
Eli Lilly and Company, through its acquisition of Prevail Therapeutics, competes in peptide drug development.
Novartis
NVS
Mkt Cap304.1B
Novartis AG engages in significant research in peptide-based drugs, competing for similar market share.
Pfizer
PFE
Mkt Cap162.16B
Pfizer Inc. has investments in peptide research and drug development, positioning it as a competitor.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG develops peptide therapeutics, directly competing with PolyPeptide in the biopharmaceutical field.
Sanofi
SNY
Mkt Cap106.01B
Sanofi SA focuses on peptide drug solutions among its diverse biopharmaceutical products, competing with PolyPeptide.
Merck
MRK
Mkt Cap370.89B
Merck & Co., Inc. has a strong focus on innovative drug development including peptides, competing in the same arena.
GSK
GSK
Mkt Cap99.96B
GlaxoSmithKline plc invests in peptide-based drug development, making it a competitor in this specialized field.

About

PolyPeptide Group AG operates as a contract development and manufacturing company in Europe, the United States, Asia Pacific, and internationally. It develops and manufactures synthetic peptides used as active pharmaceutical ingredients or intermediates in therapeutic products. The company offers portfolio of drug therapies for metabolic diseases, including the GLP-1. It also provides generic peptides and peptides used in cosmetics, animal health, and medical devices, as well as development and analytical services. The company serves academic, pharmaceutical, and biotech companies. PolyPeptide Group AG was founded in 1952 and is headquartered in Baar, Switzerland. PolyPeptide Group AG is a subsidiary of Draupnir Holding B.V.
Show more...
CEO
Mr. Juan Jose Gonzalez
Employees
1440
Country
Switzerland
ISIN
CH1110760852
WKN
000A3CNHV

Listings

F
DE
8H0.F
STU
DE
8H0.STU
MU
DE
8H0.MU
LSE
GB
0AAJ.LSE

0 Comments

Share your thoughts

FAQ

What is PolyPeptide Group stock price today?▼
The current price of 0AAJ.LSE is CHF44.00 CHF — it has increased by +0% in the past 24 hours. Watch PolyPeptide Group stock price performance more closely on the chart.
What is PolyPeptide Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on London Exchange exchange PolyPeptide Group stocks are traded under the ticker 0AAJ.LSE.
Is PolyPeptide Group stock price growing?▼
0AAJ.LSE stock has fallen by -0.13% compared to the previous week, the month change is a +0.2% rise, over the last year PolyPeptide Group has showed a +73.8% increase.
When is the next PolyPeptide Group earnings date?▼
PolyPeptide Group is going to release the next earnings report on March 09, 2027.
What is PolyPeptide Group revenue for the last year?▼
PolyPeptide Group revenue for the last year amounts to 363.03M CHF.
What is PolyPeptide Group net income for the last year?▼
0AAJ.LSE net income for the last year is -19.8M CHF.
Does PolyPeptide Group pay dividends?▼
Yes, 0AAJ.LSE dividends are paid en. The last dividend per share was 0.3 CHF. As of today, Dividend Yield (FWD)% is 0%.
How many employees does PolyPeptide Group have?▼
As of September 09, 2026, the company has 1,440 employees.
In which sector is PolyPeptide Group located?▼
PolyPeptide Group operates in the Manufacturing sector.
When did PolyPeptide Group complete a stock split?▼
PolyPeptide Group has not had any recent stock splits.
Where is PolyPeptide Group headquartered?▼
PolyPeptide Group is headquartered in Baar, Switzerland.